4-(1H-BENZOIMIDAZOL-2-YL)-2-METHYL-PHENYLAMINE
- $45 - $874
- Product name: 4-(1H-BENZOIMIDAZOL-2-YL)-2-METHYL-PHENYLAMINE
- CAS: 874591-54-5
- MF: C14H13N3
- MW: 223.27
- EINECS:
- MDL Number:MFCD05843142
- Synonyms:ART-CHEM-BB B025067;ASISCHEM B52413;ASINEX-REAG BAS 11775274;AKOS BB-7981;4-(1H-BENZOIMIDAZOL-2-YL)-2-METHYL-PHENYLAMINE;4-(1H-BENZIMIDAZOL-2-YL)-2-METHYLANILINE;TIMTEC-BB SBB009732;4-(1H-benzo[d]imidazol-2-yl)-2-methylaniline
4 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
- TRC
Package
- 10mg
- 500mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11038602
- Product description4-(1H-Benzo[d]imidazol-2-yl)-2-methylaniline 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number019431
- Product description4-(1H-Benzoimidazol-2-yl)-2-methyl-phenylamine
- Packaging500mg
- Price$188
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number019431
- Product description4-(1H-Benzoimidazol-2-yl)-2-methyl-phenylamine
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB204085
- Product description4-(1H-Benzoimidazol-2-yl)-2-methyl-phenylamine
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11038602 | 4-(1H-Benzo[d]imidazol-2-yl)-2-methylaniline 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 019431 | 4-(1H-Benzoimidazol-2-yl)-2-methyl-phenylamine | 500mg | $188 | 2021-12-16 | Buy |
Matrix Scientific | 019431 | 4-(1H-Benzoimidazol-2-yl)-2-methyl-phenylamine | 1g | $308 | 2021-12-16 | Buy |
TRC | B204085 | 4-(1H-Benzoimidazol-2-yl)-2-methyl-phenylamine | 10mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :476.5±55.0 °C(Predicted)
Density :1.247±0.06 g/cm3(Predicted)
pka :11.41±0.10(Predicted)
Density :1.247±0.06 g/cm3(Predicted)
pka :11.41±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|